🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering substances of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Elimination

According to TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially serious medical dangers”.